EUVIMEDEUVIMED entdecken
Crossref

Comparative Study of Sulfiredoxin-1 with Selected Inflammatory Markers in Chronic Kidney Disease Patients Pre- and Post-Hemodialysis

Rana I. Atiyah, Luay A. Al-Helaly, Faiz M. AL-abady

Israa University Journal for Applied Science · 01.04.2026 · 9 (1) · 1-16

DOI: 10.52865/iaqm8648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Israa University Journal for Applied Science, online erschienen am 01.04.2026. Verfasst von Rana I. Atiyah und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) is a progressive disorder defined by a persistent reduction in glomerular filtration rate below 60 mL/min/1.73 m² for at least three months. Oxidative stress(OS) play key roles in CKD progression and may be aggravated by repeated hemodialysis sessions. Sulfiredoxin-1 (Srx-1) is a recently identified antioxidant protein involved in reversing oxidative damage and regulating redox signaling; however, its clinical relevance in CKD remains unclear.

Methods

A total of 140 participants were enrolled, including 100 CKD patients on hemodialysis and 40 healthy controls. Serum levels of Srx-1, kidney injury molecule-1 (KIM-1), and interleukin-18 (IL-18) were measured using enzyme-linked immunosorbent assay. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) were determined using standard BIOLABO (France) biochemical kits.

Results

Compared with healthy controls, CKD patients showed significantly elevated levels of Srx-1, IL-18, KIM-1, and ALP, along with significantly reduced ALT and AST levels. ALT levels increased significantly after hemodialysis compared with pre-dialysis values. Patients receiving twelve dialysis sessions per month exhibited higher Srx-1, IL-18, and KIM-1 levels than those undergoing eight sessions monthly, while ALP levels were lower. No significant differences were observed regarding age, disease duration, or underlying causes between the groups.

Conclusion

The findings demonstrate a close relationship between OS inflammation, and dialysis frequency in CKD. Elevated Srx-1 levels with increased dialysis frequency may represent a compensatory antioxidant response to cumulative OS. Nevertheless, Srx-1 may not be a reliable standalone biomarker, emphasizing the need for further large-scale studies to clarify its clinical significance.

Zitieren

APA

Atiyah, R. I., Al-Helaly, L. A., & AL-abady, F. M. (2026). Comparative Study of Sulfiredoxin-1 with Selected Inflammatory Markers in Chronic Kidney Disease Patients Pre- and Post-Hemodialysis. Israa University Journal for Applied Science, 9(1), 1-16. https://doi.org/10.52865/iaqm8648

Vancouver

Atiyah RI, Al-Helaly LA, AL-abady FM. Comparative Study of Sulfiredoxin-1 with Selected Inflammatory Markers in Chronic Kidney Disease Patients Pre- and Post-Hemodialysis. Israa University Journal for Applied Science. 2026;9(1):1-16. doi:10.52865/iaqm8648

BibTeX
@article{Atiyah2026,
  author = {Atiyah, Rana I. and Al-Helaly, Luay A. and AL-abady, Faiz M.},
  title = {Comparative Study of Sulfiredoxin-1 with Selected Inflammatory Markers in Chronic Kidney Disease Patients Pre- and Post-Hemodialysis},
  journal = {Israa University Journal for Applied Science},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {1--16},
  doi = {10.52865/iaqm8648}
}
Kostenlos starten →